![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
Drug is now suitable for all age groups with multiple dosing options
Tekort aan geneesmiddelen neemt nog verder toe, minister verplicht aanleggen van voorraad
Medicijnfabrikanten hebben vorig jaar 1.390 meldingen gedaan van een dreigend geneesmiddeltekort. Een enorme stijging ten opzichte van 2017, toen er nog 536 keer aan de bel werd getrokken. De meldingen gingen over ruim...
Califonia court rules J&J must pay woman with mesothelioma $29 million
A California jury has ordered American healthcare conglomerate Johnson & Johnson to pay more than $29 million to a woman with mesothelioma who claimed asbestos in the firm’s talcum powder had caused her to develop...
De huidige marketingmix (5 P’s) wordt volledig persoonlijk
Iedereen kent de marketingmix wel. Het is een combinatie van tools die een bedrijf inzet om de marketingstrategie te behalen. Door technologische ontwikkelingen, innovaties en een veranderde markt is het traditionele...
Janssen’s ulcerative colitis treatment shows positive results in phase 3 trials
Janssen’s ulcerative colitis treatment, Stelara (ustekinumab subcutaneous) has shown positive results as maintenance therapy in phase 3 trials. The study found that 44% of patients with severe to moderate ulcerative...
“Fail Fast, But More Confidently”: Developing Organoids for Drug Development and Discovery
Richard Eglen discusses the use of organoids in drug discovery, including the screening of candidate compounds for efficacy, toxicity, and pharmacokinetics.
Parkinson’s disease: Servier and Oncodesign announce research and drug development partnership
Servier and Oncodesign have announced a strategic partnership for the research and development of potential drug candidates for Parkinson’s disease.
FDA approves a new generic valsartan
Today, the U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA prioritized the...
7 voorbeelden van buitengewone contentmarketing
Hoe ver kunnen en willen we gaan met contentcreatie? Sommige bedrijven trekken alle registers open. In dit artikel laat ik je ter inspiratie 7 voorbeelden van buitengewone contentmarketing zien. En misschien hebben de...
‘Er wordt gesjoemeld met data bij vrijwel alle medicijnen’
Van bijna alle medicijnen die de afgelopen dertig jaar zijn ontwikkeld, zijn de schadelijke effecten niet goed bekend. Dat stelt de Britse hoogleraar psychiatrie David Healy in reactie op de ophef in Nederland over...
3 Myths in Content Marketing and How to Counter Them
Ever run into someone who doesn’t “get” content marketing? They unknowingly ascribe to misunderstandings and misperceptions. Here’s how to take on three of those myths so you’re all operating from the same content...
FDA approves Pfizer’s Humira biosimilar Trazimera
Patients in the US will now be able to access another biosimilar version of AbbVie’s Humira (adalimumab) with the FDA approval of Pfizer’s Trazimera in the treatment of human epidermal growth factor receptor-2 (HER2)...
How Artificial Intelligence Could Transform Medicine
In “Deep Medicine,” Dr. Eric Topol looks at the ways that A.I. could improve health care, and where it might stumble.
Aandacht in een vluchtige wereld
Het laatste gedrukte nummer van het roemruchte Britse tijdschrift Admap ging over aandacht. Aandacht voor merken. Aandacht voor reclame. Serieuze aandacht. Krijg dat nog maar eens in deze tijd van multi-screen en van...
Rapastinel Fails to Meet Primary Endpoint in Phase 3 Adjunctive MDD Trials
Clinical studies evaluating the safety, efficacy and tolerability of rapastinel as an adjunctive treatment for major depressive disorder (MDD) did not meet primary and key secondary endpoints, according to topline...
FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults
Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed mixed judgements on its efficacy and safety in adults and children with the...
Monthly injections offer similar efficacy to daily pills in HIV phase 3 trials
A long acting, injectable two drug regimen developed by Pfizer and GSK joint venture ViiV Healthcare has similar efficacy to daily, three drug antiretroviral in adults living with HIV, according to data from two Phase 3...
Roche’s Tecentriq combo scoops up European approval in first-line metastatic lung cancer
Roche has announced the approval of the European Commission for its PD-L1 inhibitor Tecentriq (atezolizumab) when used in combination with Avastin (bevacizumab), paclitaxel and carboplatin as a first-line treatment for...
